Search Results:

Have any questions? 706-721-6582 or [email protected]

Study Name	Principal Investigator
(ARGX-113-2011) A Phase 3, Single-Arm, Multicenter, Open-Label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older with Active Idiopathic Inflammatory Myopathy	Schiopu, Elena
AMETHYST: A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy	Schiopu, Elena

RESEARCH. INNOVATION. DISCOVERY.

立即博